PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Clinical trial NCT06419621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06419621
- Sponsor
- Biotheus Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2027-07-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.